In Estonia, over 20,000 eye injections are administered annually to help slow down vision loss in the elderly population. These treatments are essential for many seniors who experience age-related eye conditions that could lead to blindness. With the introduction of a new drug set to be available in April, this scenario is expected to change significantly. This new medication has the potential to drastically reduce the number of injections that patients need to receive.